Long-term use of continuous subcutaneous insulin infusion

References 

1. Pickup J , Keen H . Continuous subcutaneous insulin infusion at 25 years. Evidence base for the expanding use of insulin pump therapy in type 1 diabetes . Diabetes Care . 2002;25:593–598
   • MEDLINE
   • CrossRef
2. Bode BW , Steed RD , Davidson PC . Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin mfusion in type 1 diabetes . Diabetes Care . 1996;19:324–327
   • MEDLINE
3. Boland EA , Grey M , Oesterle A , Fredrickson L , Tamborlane WV . Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes . Diabetes Care . 1999;22:1799; 1784
4. Pickup JC , Mattock MB , Kerry S . Glycaemic control with continuous subcutaneous insulin infusion compared to intensive insulin injection therapy in type 1 diabetes: meta-analysis of randomised controlled trials . BMJ . 2002;324:705–708
   • CrossRef
5. Pickup JC , Kidd J , Burmiston S , Yemane N . Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemiaprone type 1 diabetes: implications for NICE guidelines . Pract Diabet Int . 2005;22:10–14
6. J.C. Pickup, J. Kidd, S. Burmiston, N. Yemane, Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabet Metab Res Rev, in press.
7. Diabetes Control and Complications Trial Research Group  . The absence of a glycemic threshold for the development of longterm complications: the perspective of the Diabetes Control and Complications Trial . Diabetes . 1996;45:1289–1298
   • MEDLINE
8. Warren E , Weatherley-Jones E , Chilcott J , Beverley C . Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine . Health Technol Assess . 2004;8(No. 45):1–57
   • MEDLINE